Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility-Reference-Cited by-同舟云学术

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility

Published:2022-06-29 Issue:3 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Abbey Taylor¹,Vialichka Alesia¹,Jurkovic Michele¹,Biagi Mark²,Wenzler Eric¹^ORCID

Affiliation:

1. College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA

2. College of Pharmacy, University of Illinois Chicago, Rockford, Illinois, USA

Abstract

Treatment of infections due to Acinetobacter baumannii often involves the use of multiple antibiotics simultaneously as combination therapy, but it is unknown which antibiotics are best used together. Tetracycline agents such as minocycline and tigecycline maintain good activity against A. baumannii and are often used with one or more other agents to achieve better killing of the bacteria.

Funder

Paratek Pharmaceuticals

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00542-22

Reference61 articles.

1. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. 2017. https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed November 14 2021.

2. U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States 2019. 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed November 14 2021.

3. Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat

4. In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018

5. CLSI. 2021. Performance standards for antimicrobial susceptibility testing, M100-S31 ed. Clinical and Laboratory Standards Insitute, Wayne, PA.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates;Microorganisms;2024-07-02

2. Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential;Biomolecules;2024-06-30

3. Treatment of Acinetobacter baumannii;Acinetobacter baumannii - The Rise of a Resistant Pathogen [Working Title];2023-11-07

4. How to treat severe Acinetobacter baumannii infections;Current Opinion in Infectious Diseases;2023-09-26

5. Novel Antimicrobial Agents for Gram-Negative Pathogens;Antibiotics;2023-04-16